144913-66-6

Basic information

• Product Name: 2-Piperidinecarboxylicacid,4-hydroxy-,methylester(9CI)
• Synonyms: 2-Piperidinecarboxylicacid,4-hydroxy-,methylester(9CI);Methyl 4-hydroxypiperidine-2-carboxylate
• CAS NO: 144913-66-6
• Molecular Formula: C₇H₁₃NO₃
• Molecular Weight: 159.19
• Product Categories: CARBOXYLICESTER
• Mol File: 144913-66-6.mol

Chemical Properties

• Boiling Point: 257.2±40.0 °C(Predicted)
• Appearance: /
• Density: 1.161±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 14.53±0.40(Predicted)
• CAS DataBase Reference: 2-Piperidinecarboxylicacid,4-hydroxy-,methylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Piperidinecarboxylicacid,4-hydroxy-,methylester(9CI)(144913-66-6)
• EPA Substance Registry System: 2-Piperidinecarboxylicacid,4-hydroxy-,methylester(9CI)(144913-66-6)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 144913-66-6(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
2-Piperidinecarboxylic acid, 4-hydroxy-, methyl ester (9CI) is used as a building block in the synthesis of various organic compounds. Its unique structure allows for the creation of a wide range of molecules with different properties and applications.
Used in Pharmaceutical Applications:
2-Piperidinecarboxylic acid, 4-hydroxy-, methyl ester (9CI) is used as an intermediate in the development of pharmaceutical products. Its presence in the compound structure can contribute to the overall efficacy and properties of the final drug product, making it a valuable component in the pharmaceutical industry.
Used in Chemical Research:
2-Piperidinecarboxylic acid, 4-hydroxy-, methyl ester (9CI) is used as a research tool in the field of chemistry. It can help scientists understand the behavior of different functional groups and their interactions with other molecules, which is crucial for the advancement of chemical knowledge and the development of new compounds.

Upstream product

• 847029-99-6 1-benzyl 2-methyl 4-hydroxypiperidine-1,2-dicarboxylate 
• 67-56-1 methanol 

Downstream Products

• 81357-18-8 4-oxo-piperidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester 
• 1259012-00-4 tert-butyl 2-((2-(5-chloro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-ylamino)methyl)-4,4-difluoropiperidine-1-carboxylate 
• 1259011-99-8 (±) tert-butyl 2-(aminomethyl)-4,4-difluoropiperidine-1-carboxylate 
• 1255666-28-4 1-tert-butyl 2-methyl 4,4-difluoropiperidine-1,2-dicarboxylate 
• 847029-99-6 1-benzyl 2-methyl 4-hydroxypiperidine-1,2-dicarboxylate 
• 1259011-96-5 (±)-methyl 1-benzyloxycarbonyl-4,4-difluoropiperidine-2-carboxylate 
• 125104-19-0 (±)-methyl 1-benzyloxycarbonyl-4-oxopiperidine-2-carboxylate 
• 187753-13-5 N-tert-butoxycarbonyl-cis-4-hydroxy-L-pipecolinic acid methyl ester 

Relevant articles and documents

MACROCYCLIC SERINE PROTEASE INHIBITORS

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

NEW COMPOUNDS

The present invention relates to new compounds of formula I, wherein P Q X1 X2 X3 X4 X5 R R1 R2 R3 R4R5 G M1 M2 M3 m and n are defined as in formula I, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.

Efflux pump inhibitors

Compounds are described which have efflux pump inhibitor activity. Also described are methods of using such efflux pump inhibitor compounds and pharmaceutical compositions which include such compounds.